Organization
Merck & Co., Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Merck & Co., Inc.
... brings over 25 years of global pharmaceutical and vaccine experience with Merck & Co, Inc. to his new position at Immunovaccine. His experience includes launching ...
... combination of BL-8040 and KEYTRUDA® (pembrolizumab), an anti-PD-1 therapy marketed by Merck & Co., Inc., Kenilworth, N.J., USA (known as MSD outside the United States ...
... and inclusion commitments. The summit was hosted by global biopharmaceutical company, Merck & Co., Inc. "This business community is united in our dedication to further ...
... Skittish investors grew increasingly concerned last year that Merck & Co. couldn’t replicate a Keytruda-chemo combo's phase 2 success in previously untreated ...
... They include some of the industry's most recognizable names (AstraZeneca, Celgene, and Merck) and life sciences upstarts like Rigontec, CureVac, and IFM Therapeutics. Nominees were ...
... is Vice President and Chief Information Officer for Manufacturing IT at Merck & Co., Inc. "Being elected to the Board of Governors is a tremendous ...
... are the main sponsors of migraine clinical trials, such as GlaxoSmithKline, Merck & Co, Allergan, Eli Lilly, Johnson & Johnson, Pfizer, and Teva.Many of the ...
... SAN FRANCISCO—The good news about drug pricing pressure, according to Merck & Co. CEO Ken Frazier? It won't get much worse. Merck, along with ...
... (U.S.), GlaxoSmithKline, plc (U.K.), Johnson & Johnson (U.S.), MedImmune, LLC (U.S.), Merck & Co., Inc. (U.S.), Pfizer, Inc. (U.S.), Sanofi Pasteur SA (France), Serum Institute ...
... our first thought to patients, we are committed to working closely with Merck and the FDA to expedite this clinical program with the hope that ...
... of the lung and TNBC are conducted in collaboration with Merck & Co. Inc. (MSD), through a subsidiary. In addition, a number of investigator-sponsored trials ...
... ers Merck Merck CEO: We continue to work with Trump Administration to try and ...
... smaller portion of repatriated cash will be used to reduce our debt." Merck Merck has said it views deals as ways to boost its pipeline. ...
... and head of the Center for Observational and Real-World Evidence (CORE) at Merck, also a member organization. "ICER has made great progress, but significant areas ...
... in high places, it's 'time for action' to ease drug costs Merck & Co.'s top executive said Monday that pricing pressure isn't likely to get ...
... David Michelson, M.D., who led the failed Alzheimer’s BACE inhibitor program, left Merck after 11 years to become CMO of Proclara Biosciences. FierceBiotech > Backed ...
... Robert Davis, CFO and Executive Vice President of global services at Merck & Co., Inc., as a new Board member, effective January 08th, 2018. Davis ...
... a part of Healthcare Services and Solutions, a wholly-owned subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA. HMR specializes in improving the healthcare experience ...
... Merck (NYSE: MRK), known as MSD outside the United States and Canada, will hold ...
... data from that study, the Company has entered into an agreement with Merck (d.b.a. as Merck Sharp & Dohme outside the United States and Canada) ...
... of galinpepimut-S (GPS), our Wilms Tumor 1-targeting immunotherapy, through collaborations with Merck & Co., among others, as well as our ongoing Phase 2 trials of ...
... in the biopharmaceutical industry, including serving as chief marketing officer at Merck & Co. Inc. "Wendy is an accomplished biopharmaceutical executive with a proven track ...
Want to see the full history on Merck & Co., Inc.? Upgrade to RelSci Pro now!
Start My Free Trial